BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 18449891)

  • 21. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
    Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
    Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
    Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
    Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
    World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
    Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
    Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1.
    Cao W; Wei W; Zhan Z; Xie Y; Xiao Q
    Oncol Rep; 2016 May; 35(5):2583-91. PubMed ID: 26936591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
    Zhuang K; Zhang L; Zhang X; Tang H; Zhang J; Yan Y; Han K; Guo H
    Int J Oncol; 2017 Jun; 50(6):2091-2100. PubMed ID: 28498440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.
    Xu K; Liang X; Shen K; Sun L; Cui D; Zhao Y; Tian J; Ni L; Liu J
    Exp Cell Res; 2012 Oct; 318(17):2168-77. PubMed ID: 22677042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1.
    Zhang Y; Qu X; Li C; Fan Y; Che X; Wang X; Cai Y; Hu X; Liu Y
    Tumour Biol; 2015 Apr; 36(4):2277-85. PubMed ID: 25407491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901].
    He QC; Zhang GY; Cao WJ
    Ai Zheng; 2008 Apr; 27(4):337-42. PubMed ID: 18423116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
    Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32.
    Hong L; Wang J; Han Y; Zhao Y; Gao J; Wang J; Han Y; Zhang X; Yan L; Zhou X; Qiao T; Chen Z; Fan D
    Cell Biol Int; 2007 Sep; 31(9):1010-5. PubMed ID: 17470401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis.
    Shi Y; Zhai H; Wang X; Han Z; Liu C; Lan M; Du J; Guo C; Zhang Y; Wu K; Fan D
    Exp Cell Res; 2004 Jun; 296(2):337-46. PubMed ID: 15149863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
    Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
    J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
    Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting
    Tan B; Li Y; Zhao Q; Fan L; Wang D
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
    Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
    Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.